Redmile Group, LLC Global Blood Therapeutics, Inc. Transaction History

Redmile Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $8.53 Million - $10.9 Million	-188,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $1.07 Million - $1.29 Million	20,400 Added 12.17%	188,000 $9.89 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $5.29 Million - $7.82 Million	167,600 New	167,600 $6.88 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.